- Home
- CBNK vs DRTS Comparison
CBNK vs DRTS Comparison
Compare CBNK & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CBNK | DRTS |
|---|---|---|
| Founded | 1974 | 2015 |
| Country | United States | Israel |
| Employees | N/A | 125 |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 440.4M | 607.1M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | CBNK | DRTS |
|---|---|---|
| Price | $29.60 | $7.12 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $34.00 | $8.00 |
| AVG Volume (30 Days) | 44.6K | ★ 367.3K |
| Earning Date | 01-22-2026 | 11-20-2025 |
| Dividend Yield | ★ 1.62% | N/A |
| EPS Growth | ★ 26.24 | N/A |
| EPS | ★ 2.95 | N/A |
| Revenue | ★ $222,152,000.00 | N/A |
| Revenue This Year | $44.59 | N/A |
| Revenue Next Year | $6.44 | N/A |
| P/E Ratio | $10.02 | ★ N/A |
| Revenue Growth | ★ 40.71 | N/A |
| 52 Week Low | $24.69 | $2.30 |
| 52 Week High | $36.40 | $7.89 |
Technical Indicators
Market Signals| Indicator | CBNK | DRTS |
|---|---|---|
| Relative Strength Index (RSI) | 64.49 | 67.80 |
| Support Level | $27.78 | $6.45 |
| Resistance Level | $29.03 | $5.14 |
| Average True Range (ATR) | 0.52 | 0.54 |
| MACD | 0.12 | 0.17 |
| Stochastic Oscillator | 84.14 | 75.64 |
Price Performance
Historical ComparisonAbout CBNK Capital Bancorp Inc.
Capital Bancorp Inc is a bank holding company. The company through its holdings operates as a commercial-focused community bank that serves businesses, not-for-profit associations, and entrepreneurs throughout the region. The bank operates through four divisions including Commercial Banking, Capital Bank Home Loans, OpenSky, and Windsor Advantage, and also operates in five business segments: commercial banking; mortgage banking; credit cards; government loan servicing; and corporate activities.
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.